---
figid: PMC5520933__cddis2017279f1
figtitle: The lithium targeted cellular and molecular mechanism by activating several
  neurotrophic and associated signaling in Alzheimer’s disease
organisms:
- Bos taurus
- Oryctolagus cuniculus
- Capra hircus
- Equus asinus
- Pekania pennanti
- Mus musculus
- Rattus norvegicus
- Homo sapiens
organisms_ner:
- Equus asinus
- Oryctolagus cuniculus
- Homo sapiens
- Mus musculus
- Rattus norvegicus
- Bos taurus
- Capra hircus
- Drosophila melanogaster
pmcid: PMC5520933
filename: cddis2017279f1.jpg
figlink: /pmc/articles/PMC5520933/figure/fig1/
number: F1
caption: Schematic illustration of the lithium targeted cellular and molecular mechanism
  by activating several neurotrophic and associated signaling in Alzheimer’s disease.
  Lithium inhibit GSK3 (both α and β isoforms) and inositol mono/polyphosphatase (IMPase,
  IPPase) activity. The inhibition of GSK3 by lithium reduces tau phosphorylation
  and production of Aβ peptides by interfering γ-secretase cleavage of APP processing.
  In addition, inhibition of inositol monophosphatse by lithium may regulate clearance
  of aggregated phosphorylated tau and Aβ peptides. Moreover, lithium increases the
  expression of BDNF, which activates the ERK/MAPK pathway and further increases the
  expression of nuclear transcription factor cAMP response element (CREB). Accordingly,
  activation of BDNF may upregulates neurogenesis and downregulates pro-inflammatory
  responses (IL-1β and TNFα) in Alzheimer’s disease
papertitle: LISPRO mitigates β-amyloid and associated pathologies in Alzheimer’s mice.
reftext: Ahsan Habib, et al. Cell Death Dis. 2017 Jun;8(6):e2880.
year: '2017'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.6249148
figid_alias: PMC5520933__F1
figtype: Figure
redirect_from: /figures/PMC5520933__F1
ndex: 87cceae7-df07-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5520933__cddis2017279f1.html
  '@type': Dataset
  description: Schematic illustration of the lithium targeted cellular and molecular
    mechanism by activating several neurotrophic and associated signaling in Alzheimer’s
    disease. Lithium inhibit GSK3 (both α and β isoforms) and inositol mono/polyphosphatase
    (IMPase, IPPase) activity. The inhibition of GSK3 by lithium reduces tau phosphorylation
    and production of Aβ peptides by interfering γ-secretase cleavage of APP processing.
    In addition, inhibition of inositol monophosphatse by lithium may regulate clearance
    of aggregated phosphorylated tau and Aβ peptides. Moreover, lithium increases
    the expression of BDNF, which activates the ERK/MAPK pathway and further increases
    the expression of nuclear transcription factor cAMP response element (CREB). Accordingly,
    activation of BDNF may upregulates neurogenesis and downregulates pro-inflammatory
    responses (IL-1β and TNFα) in Alzheimer’s disease
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - GSK3A
  - BDNF
  - IL18
  - TNF
  - APP
  - REST
  - HM13
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - EPHB2
  - MAPK1
  - MAPK3
  - AKT1
  - AKT2
  - AKT3
  - HSPG2
  - PLCE1
  - PLCZ1
  - PLCB1
  - PLCB2
  - PLCB3
  - PLCB4
  - PLCD1
  - PLCD3
  - PLCD4
  - PLCG1
  - PLCG2
  - BDNF-AS
  - CREB1
  - CREB3
  - CREB5
  - CREB3L1
  - CREB3L2
  - CREB3L3
  - CREB3L4
  - CREM
  - ATF1
  - ATF2
  - MAPT
  - SUCLA2
  - NR4A3
  - Gsk3a
  - Pik3r1
  - Ephb2
  - Mapk1
  - Akt1
  - Hspg2
  - Bdnf
  - Creb1
  - Il18
  - Tnf
  - Mapt
  - Csnk1e
  - App
  - Rest
  - H2-Ab1
  - Nr4a3
  - Th
  - Pik3cg
  - Ephb1
  - RESTB
  - E(spl)mgamma-HLH
  - sgg
  - Pk34A
  - Ipp
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Erk7
  - rl
  - Akt
  - norpA
  - sl
  - Plc21C
  - CrebB
  - CrebA
  - egr
  - tau
  - app
  - Appl
  - ApepP
  - APP-BP1
  - Abi
  - ab
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
---
